| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/24/2002 | WO2001012819A3 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 01/24/2002 | WO2001000655A3 Therapeutic peptides derived from subsequences of bpi |
| 01/24/2002 | WO2000069428A3 Anionic polymers as toxin binders and antibacterial agents |
| 01/24/2002 | US20020010949 Cloning using donor nuclei from differentiated fetal and adult cells |
| 01/24/2002 | US20020010338 Phenyl-keto-imidazolidine thioamide derivatives |
| 01/24/2002 | US20020010318 Enzyme inhibitor; for use in treatment of lung defects, asthma, bronchitis, emphysema and respiratory system disorders |
| 01/24/2002 | US20020010203 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 01/24/2002 | US20020010196 Antiulcer agents, treatment of gastroesophageal reflux and other conditions related to gastric hypersecretion such as Zollinger-Ellison syndrome |
| 01/24/2002 | US20020010190 N-heterocyclic derivatives as NOS inhibitors |
| 01/24/2002 | US20020010185 Anticarcinogenic agents |
| 01/24/2002 | US20020010174 1,4-diazepine-2-one derivatives as neurokinin antagonist |
| 01/24/2002 | US20020010170 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli |
| 01/24/2002 | US20020010146 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 01/24/2002 | US20020010133 Method for preventing gastritis using amylin or amylin agonists |
| 01/24/2002 | US20020009776 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/24/2002 | US20020009478 Aqueous liquid containing colloidal particles |
| 01/24/2002 | US20020009446 Method of modulating memory effector T-cells and compositions |
| 01/24/2002 | DE10033459A1 New aminomethyl-substituted bicyclic compounds, useful for treating urinary incontinence, pruritis, tinnitus, diarrhea or especially pain |
| 01/24/2002 | CA2418288A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 01/24/2002 | CA2418214A1 Antimicrobial agent |
| 01/24/2002 | CA2416285A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/24/2002 | CA2416248A1 5-substituted 2-aryl-4-pyrimidinones |
| 01/24/2002 | CA2416245A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 01/24/2002 | CA2416015A1 Matrix metalloproteinase inhibitors |
| 01/24/2002 | CA2415938A1 Alpha-msh related compounds and methods of use |
| 01/24/2002 | CA2415935A1 Novel 6-heteroarylphenanthridines |
| 01/24/2002 | CA2415906A1 Compositions containing diacyltartaric salts of (e)-metanicotine |
| 01/24/2002 | CA2415896A1 Use of fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel |
| 01/24/2002 | CA2415673A1 Tetrazole derivatives |
| 01/24/2002 | CA2415557A1 Compounds for the treatment of sexual dysfunction |
| 01/24/2002 | CA2415392A1 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 01/24/2002 | CA2414783A1 Treatment of eating disorders using carboxyalkylethers |
| 01/23/2002 | EP1174146A1 Agents for ameliorating pancreatic function disorder |
| 01/23/2002 | EP1174136A2 Oral pharmaceutical dosage form containing a proton pump inhibitor |
| 01/23/2002 | EP1174130A2 Use of preparations of curcuma plants |
| 01/23/2002 | EP1173767A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/23/2002 | EP1173569A1 Synthetic signalling molecules |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173485A1 Human antibodies to staphylococcus aureus |
| 01/23/2002 | EP1173484A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173465A1 Novel human voltage-gated potassium channel |
| 01/23/2002 | EP1173462A1 50 human secreted proteins |
| 01/23/2002 | EP1173443A1 Cyclic urea and cyclic amide derivatives |
| 01/23/2002 | EP1173440A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 01/23/2002 | EP1173439A1 Haloalkoxy imidazonaphthyridines |
| 01/23/2002 | EP1173438A1 Substituted imidazoles, their preparation and use |
| 01/23/2002 | EP1173429A1 Protease inhibitors |
| 01/23/2002 | EP1173427A1 Hydroxamic acid derivative |
| 01/23/2002 | EP1173420A2 Heterocyclic compounds having antitumor activity |
| 01/23/2002 | EP1173252A1 Products and methods for brachytherapy |
| 01/23/2002 | EP1173218A1 Compositions for treatment of disorders of the oesophagus |
| 01/23/2002 | EP1173215A1 Over-coated chewing gum formulations |
| 01/23/2002 | EP1173201A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 01/23/2002 | EP1173189A1 Asialocytokines and treatment of liver disease |
| 01/23/2002 | EP1173187A2 Combined preparations comprising morpholine anthracyclines and anticancer agent |
| 01/23/2002 | EP1173183A2 Use of compounds with a nitrogen-oxygen heterocycle |
| 01/23/2002 | EP1173173A1 Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives |
| 01/23/2002 | EP1173170A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/23/2002 | EP1173160A1 (e)-styryl sulfone anticancer agents |
| 01/23/2002 | EP1173155A1 Gum pad for delivery of medication to mucosal tissues |
| 01/23/2002 | EP1173152A2 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers |
| 01/23/2002 | EP1025100B1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 01/23/2002 | EP0854711B1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 01/23/2002 | EP0739903B1 Carbamoylmethylurea derivative |
| 01/23/2002 | CN1332801A Connective tissue growth factor (CTGF) and methods of use |
| 01/23/2002 | CN1332744A Tricyclic delta 3-piperidines as alpha 2-antagonists |
| 01/23/2002 | CN1332741A Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 01/23/2002 | CN1332727A 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/23/2002 | CN1332724A N-arylsulfonyl amino acid omega amides |
| 01/23/2002 | CN1332632A Preventives for hepatopathy |
| 01/23/2002 | CN1332631A Composition and method for increasing weight gain and feed efficiency |
| 01/23/2002 | CN1332626A Inhalation system |
| 01/23/2002 | CN1332240A Superoxide dismutase-4 |
| 01/23/2002 | CN1332238A Tonic turtle wine |
| 01/23/2002 | CN1332015A Freeze dried dyad live hepatitis A and parotitis vaccine |
| 01/23/2002 | CN1332014A Solid fermentation process of producing waxy microecological bacillus prepn |
| 01/23/2002 | CN1332013A Granule for clearing away heat and dispelling watness-evil |
| 01/23/2002 | CN1331996A Hepatitis B treaitng pill |
| 01/23/2002 | CN1331988A Stone expelling medicine powder |
| 01/23/2002 | CN1331986A Genetic medicine product prepared with edible fungi and Chinese medicine material and its prepn technology |
| 01/23/2002 | CN1078080C Zinc-contg. haw oral liquid and its prepairng process |
| 01/22/2002 | US6340699 SPLA2 inhibitor compounds for treatment of disease |
| 01/22/2002 | US6340695 Rapid onset formulation |
| 01/22/2002 | US6340694 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 01/22/2002 | US6340685 Antiinflammatory agents |
| 01/22/2002 | US6340681 Useful as analgesics in mammals |
| 01/22/2002 | US6340459 Administering to agent capable of inhibiting interaction between cd40 ligand and the cells to inhibit activation of the cells in therapy of reperfusion injury, in an non-transplant recipient |
| 01/22/2002 | US6340457 Pharmaceutical and alimentary compositions containing bacteria of genus acetobacter |
| 01/22/2002 | US6340456 For oral hygiene, drugs |
| 01/22/2002 | CA2259962C Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/22/2002 | CA2237971C Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 01/22/2002 | CA2149333C Eck receptor ligands |
| 01/17/2002 | WO2002004641A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004640A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004639A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004624A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004509A2 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 01/17/2002 | WO2002004490A2 Lipid metabolism molecules |